𝔖 Bobbio Scriptorium
✦   LIBER   ✦

975 A phase I/II single arm trial to determine the safety, tolerability, and biological activity of intrahepatic delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers (MTC-DOX) in patients with metastatic tumors in the liver

✍ Scribed by R. Just; C. Hoh; T. Vogl; P. Neese; J. Doemeny; M. Schechter; R. Varney; W. Stanton; M. Schiemann; P. Goldfarb


Book ID
118621141
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
342 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.